BIO-RAD LABORATORIES, INC. — Director's Dealing 2023

Mar 9, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-RAD LABORATORIES, INC. (BIO BIOB)
CIK: 0000012208
Period of Report: 2023-03-08

Reporting Person: ERNST TIMOTHY S (EVP, General Counsel & Sec)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-03-08	Bio-Rad A Common Stock	M	850	$159.32	Acquired	4267.3635	Direct
2023-03-08	Bio-Rad A Common Stock	M	150	$215.98	Acquired	4417.3635	Direct
2023-03-08	Bio-Rad A Common Stock	S	1000	$486.08	Disposed	3417.3635	Direct
2023-03-08	Bio-Rad A Common Stock	S	746	$486.89	Disposed	2671.3635	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-03-08	Non-Qualified Stock Option (right to buy)	$159.32	M	850	Disposed	2026-09-07	Bio-Rad A Common Stock (850)	Direct
2023-03-08	Non-Qualified Stock Option (right to buy)	$215.98	M	150	Disposed	2027-09-05	Bio-Rad A Common Stock (150)	Direct

Footnotes

F1: Includes 12.1510 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 09/30/2022.

F2: The option, representing a right to purchase a total of 2,500 shares, became exercisable in five equal annual installments beginning on September 7, 2017, which was the first anniversary of the date on which the option was granted.

F3: The option, representing a right to purchase a total of 2,500 shares, became exercisable in five equal annual installments beginning on September 5, 2018, which was the first anniversary of the date on which the option was granted.